Symbol="ACRV"
AssetType="Common Stock"
Name="Acrivon Therapeutics Inc. Common Stock"
Description="Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of precision cancer medicines. The company is headquartered in Watertown, Massachusetts."
CIK="1781174"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="250833000"
EBITDA="-39394000"
PERatio="None"
PEGRatio="None"
BookValue="7.32"
DividendPerShare="0"
DividendYield="0"
EPS="-1.41"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.142"
ReturnOnEquityTTM="-0.283"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.41"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="22.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-9.39"
Beta="None"
num_52WeekHigh="25.47"
num_52WeekLow="8.06"
num_50DayMovingAverage="12.67"
num_200DayMovingAverage="14.04"
SharesOutstanding="21926000"
DividendDate="None"
ExDividendDate="None"
symbol="ACRV"
open="11.39"
high="12.52"
low="11.20"
price="11.44"
volume="18572.00"
latest_trading_day="2023-07-07"
previous_close="11.65"
change="-0.21"
change_percent="-1.8447%"
aroon_positive_momentum_days="30"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="30"
Volume_recent_avg="62127"
Change_recent_avg="-0.09"
Delta_recent_avg="1.41"
Variance_recent_avg="0.7"
Change_ratio_recent_avg="-0.97"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="30"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="97"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0079.jpeg"
image_negative_thumbnail_id_2="1131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_neutral_thumbnail_id_1="594"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_neutral_thumbnail_id_2="578"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_positive_thumbnail_id_1="1013"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_positive_thumbnail_id_2="960"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0122.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
